WIF-1 GENE METHYLATION IN CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS ArticleSukhikh G.T., Ashrafyan L.A., Bairamova G.R., Babkina I.O., Chernova V.F., Osipyants A.I., Korolkova A.I., Poloznikov A.A., Asfarova G.R., Mullabaeva S.M., Kogan E.A., Muizhnek E.L., Drukh V.M., Kiselev V.I.Akusherstvo i Ginekologiya. 2017. P.. 114-123
FIRST RESULTS OF THE DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED MULTICENTER CLINICAL TRIAL OF DIM-BASED THERAPY DESIGNED AS PERSONALIZED APPROACH TO REVERSE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) ArticlePaltsev M., Kiselev V., Drukh V., Muyzhnek E., Kuznetsov I., Andrianova E., Baranovskiy P.EPMA Journal. Vol. 7. 2016.
DOUBLE-BLIND RANDOMIZED PLACEBOCONTROLLED MULTICENTER CLINICAL TRIAL (PHASE IIA) ON DIINDOLYLMETHANE'S EFFICACY AND SAFETY IN THE TREATMENT OF CIN: IMPLICATIONS FOR CERVICAL CANCER PREVENTION ArticleAshrafian L., Sukhikh G., Kiselev V., Paltsev M., Drukh V., Kuznetsov I., Muyzhnek E., Apolikhina I., Andrianova E.EPMA Journal. Vol. 6. 2015.
PHARMACOKINETIC STUDY OF THE PHARMACEUTICAL COMPOSITION BASED ON DIINDOLYLMETHANE IN FEMALE PATIENTS WITH ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA ArticleAndrianova E., Paltsev M., Kiselev V., Drukh V., Muyzhnek E., Kuznetsov I.Biology and Medicine. Vol. Vol7. 2015.
STUDY TO ASSESS SAFETY AND TOLERABILITY OF THE PHARMACEUTICAL COMPOSITION BASED ON DIINDOLYLMETHANE IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA ArticleAndrianova E., Paltsev M., Kiselev V., Drukh V., Muyzhnek E., Kuznetsov I.Biology and Medicine. Vol. Vol7. 2015.
SAFETY AND TOLERABILITY OF DIM-BASED THERAPY DESIGNED AS PERSONALIZED APPROACH TO REVERSE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) ArticlePaltsev M., Kiselev V., Muyzhnek E., Drukh V., Kuznetsov I., Pchelintseva O.EPMA Journal. Vol. 5. 2014.
PRECLINICAL ANTITUMOR ACTIVITY OF THE DIINDOLYLMETHANE FORMULATION IN XENOGRAFT MOUSE MODEL OF PROSTATE CANCER ArticleKiselev V.I., Drukh V.M., Muyzhnek E.L., Kuznetsov I.N., Pchelintseva O.I., Paltsev M.A.Experimental Oncology. Vol. 36. 2014. P.. 90-93